KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015

Background: Mutations in KRAS and NRAS often result in constitutive activation of RAS in the epidermal growth factor receptor (EGFR) signaling pathway. Mutations in KRAS exon 2 (codon 12–13) predict resistance to anti-EGFR targeted therapy in patients with metastatic colorectal carcinoma (mCRC). How...

Full description

Bibliographic Details
Main Authors: Raja Jouini, Marwa Ferchichi, Ehsen BenBrahim, Imen Ayari, Fatma Khanchel, Wafa Koubaa, Olfa Saidi, Riadh Allani, Aschraf Chadli-Debbiche
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844018373766